Previous close | 27.00 |
Open | 44.10 |
Bid | 25.90 |
Ask | 26.80 |
Strike | 230.00 |
Expiry date | 2024-12-20 |
Day's range | 43.60 - 44.10 |
Contract range | N/A |
Volume | |
Open interest | 9 |
Envista (NVST) registers a year-over-year decline in both segments in the first quarter of 2024.
Investors are optimistic about Quest Diagnostics (DGX) on strong legacy business growth.
BD's (BDX) overall top line benefits from revenue growth in all segments and both geographic regions in the fiscal second quarter.